Viciana I, González-Domenech C M, Palacios R, Delgado M, Del Arco A, Tellez F, Jarilla F, Fernández S, Clavijo E, Santos J
UGCI de Enfermedades Infecciosas y Microbiología Clínica, Hospital Virgen de la Victoria, Málaga, Spain Instituto de Investigación de Biomedicina de Málaga (IBIMA), Malaga, Spain.
Instituto de Investigación de Biomedicina de Málaga (IBIMA), Malaga, Spain.
J Antimicrob Chemother. 2016 Feb;71(2):357-61. doi: 10.1093/jac/dkv332. Epub 2015 Oct 19.
We describe the characteristics of an HIV-1 strain with six viral reverse transcriptase mutations (D67N, T69N/D, V118I, V179D, T215S and K219Q), which we have called the Malaga strain. This strain was detected in treatment-naive patients from southern Spain.
The study was undertaken at the Virgen de la Victoria Hospital, Malaga, a reference centre for the study of HIV-1 genotype resistance in Andalusia (the 'Costa del Sol'), Spain. Genotypic resistance testing was done in an automated sequencer. Phylogenetic analysis was performed using a 630 bp region of the reverse transcriptase with the mutations mentioned.
Between 2007 and 2014, we detected the Malaga strain in 30 treatment-naive patients. All were MSM, seen at five hospitals on the Costa del Sol. In all cases, the HIV-1 was subtype B with viral tropism R5. Phylogenetic analysis based on the reverse transcriptase sequence showed consistent grouping (with a bootstrap value of the common node of 100%) of the isolates that shared the mutation pattern mentioned. This strain has not been detected elsewhere or in previously treated patients. All of the patients treated with first-line combination ART responded.
We report a cluster of an HIV-1 strain with multiple resistance mutations that was transmitted over a period of >8 years, affecting 30 naive patients from the same geographical area. The strain was susceptible to first-line combination ART.
我们描述了一种具有六个病毒逆转录酶突变(D67N、T69N/D、V118I、V179D、T215S和K219Q)的HIV-1毒株的特征,我们将其称为马拉加毒株。该毒株在西班牙南部未接受过治疗的患者中被检测到。
该研究在马拉加的维多利亚圣母医院进行,该医院是西班牙安达卢西亚(“太阳海岸”)HIV-1基因型耐药性研究的参考中心。在自动测序仪上进行基因型耐药性检测。使用包含上述突变的逆转录酶630 bp区域进行系统发育分析。
2007年至2014年期间,我们在30例未接受过治疗的患者中检测到了马拉加毒株。所有患者均为男男性行为者,在太阳海岸的五家医院就诊。所有病例中,HIV-1均为B亚型,病毒嗜性为R5。基于逆转录酶序列的系统发育分析显示,具有上述突变模式的分离株一致聚类(共同节点的自展值为100%)。该毒株在其他地方或先前接受过治疗的患者中均未被检测到。所有接受一线联合抗逆转录病毒治疗的患者均有反应。
我们报告了一群具有多重耐药突变的HIV-1毒株,其传播超过8年,影响了来自同一地理区域的30例未接受过治疗的患者。该毒株对一线联合抗逆转录病毒治疗敏感。